Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: Observations from the Canadian Trial of Atrial Fibrillation

Cardiac Electrophysiology Review

Volumn 7, Issue 3, 2003, Pages 276-279

  Dorian, Paul ^a   Mangat, Iqwal ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Atrial fibrillation; Quality of life

Indexed keywords

AMIODARONE; PROPAFENONE; SOTALOL;

ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; DRUG USE; FEMALE; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART RATE AND RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTICENTER STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; SINUS RHYTHM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; WELLBEING;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEALTH STATUS INDICATORS; HUMANS; PROPAFENONE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; SOTALOL;

EID: 1342265962     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000012395.33292.cd     Document Type: Article

References (9)

1. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B, for the Canadian Trial of Atrial Fibrillation (CTAF) Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-920.
2. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers G, Carom J, Akhtar M, Luderitz B. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Amer Coll Cardiol 2000;36:1303-1309.
3. Goldberg A, Menen M, Mickelsen S, MacIndoe C, Binder M, Nawman R, West G, Kusumoto FM. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J Interv Card Electrophysiol 2003;8:59-64.
4. Spurrell P, Mitchell A, Kamalvand K, Sulke N. Quality of life after use of the patient activated atrial defibrillator. Int J Clin Pract 2003;57:30-34.
5. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2(2):121-135.
6. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whalley D, Kanagaratnam L, Heddle W, Leitch J, Perks A, Ferguson L, Bulsara M. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIR-CRAFT). J Am Coll Cardiol 2003;41:1697-1702.
7. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347(23):1825-1833.
8. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): A randomised trial. Lancet 2000;356:1789-1794.
9. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U; STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-1696.